| |
PRZOOM - /newswire/ -
Holmes Chapel, Cheshire, United Kingdom, 2010/07/08 - The Scott Partnership today announced that it has been appointed by Quotient Bioresearch, a leading provider of early stage and specialist drug development services, to lead the company’s global PR campaign.
|
| |
B2B PR agency The Scott Partnership today announced that it has been appointed by Quotient Bioresearch, a leading provider of early stage and specialist drug development services, to lead the company’s global PR campaign. Following a multi-way pitch, The Scott Partnership, headquartered in Cheshire, UK, was appointed as a result of the agency’s strong track record of delivering expert communications strategies aligned with business objectives to companies in the life sciences industry.
Founded in 2007, Quotient Bioresearch (quotientbioresearch.com) has grown rapidly through a combination of both acquisition-led and organic growth, completing a total of seven acquisitions in just three years of operation. Underpinned by a unique combination of clinical, chemical and biological capabilities, Quotient Bioresearch continually strives to deliver the highest quality of early stage and specialist drug development services in support of its pharmaceutical client base. The company’s extensive range of capabilities span Chemistry and Metabolism, Bioanalytical Sciences and Clinical Services provided independently or integrated into tailored work programmes. Quotient Bioresearch serves a broad scope of customers ranging from global pharmaceutical and clinical companies through to small virtual biotechnology organisations based in the US, Europe and Japan.
During the pitch process Quotient Bioresearch was impressed by The Scott Partnership’s multinational reach and its emphasis on demonstrating return on investment. The agency’s ethos and reputation for delivering effective, results-focused PR campaigns to a number of global organisations in the clinical, biotechnology and pharmaceutical sectors also played a vital role in the decision. Combining strong marketing, communications and public relations knowledge and experience, the agency’s expert team will be planning and managing a global PR campaign for Quotient Bioresearch that will increase awareness and visibility of the company and its breakthrough services.
Nicola Booton-Mander, Group Marketing Communications Manager of Quotient Bioresearch, comments: “The Scott Partnership has been selected over competitive agencies because of the team’s in-depth understanding of technical subjects, ability to deliver a quick turnaround of tangible results and multiple geographic locations. We are delighted to be working with the team to strengthen the brand, reinforce the benefits of our combined service offering and to communicate Quotient Bioresearch as the leading provider of early stage and specialist drug development services.”
The Scott Partnership, headquartered near Manchester, UK, was set up in 1996 as a specialist business-to-business PR consultancy for the scientific and technology industries. The company has expanded year-on-year and is committed to building strong and lasting relationships with both its clients and the media. The addition of Quotient Bioresearch to The Scott Partnership’s client portfolio is the latest in a series of new account appointments over the last three months.
|
pr[.]scottpr.com 
